Robot-Assisted lung biopsy under the microscope: will it deliver?
NCT ID NCT06004440
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking over 1,300 people who are having a lung biopsy or lesion localization with the Ion Endoluminal System, a robotic device. The goal is to see how often the device successfully gets a diagnosis and how often complications like a collapsed lung or bleeding occur. It's an observational study, meaning doctors use the device as they normally would, and researchers collect the results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ion Endoluminal System (a robotic-assisted device for lung biopsy)
- What this could lead to
- If successful, this study could confirm that the Ion system is effective and safe for routine lung biopsies, potentially improving diagnosis of lung cancer.
- What could go wrong
- This is an observational study, not a controlled trial, so results may not prove the device is better than other methods. Risks like pneumothorax or bleeding are being tracked but not compared.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascension Alexian Brothers
Elk Grove Village, Illinois, 60007, United States
-
Atrium Health of the Carolinas
Charlotte, North Carolina, 28203, United States
-
Aurora Medical Center Kenosha
Kenosha, Wisconsin, 53143, United States
-
Blessing Hospital
Quincy, Illinois, 62301, United States
-
Centennial Medical Center
Nashville, Tennessee, 37203, United States
-
Cone Health Moses Cone Memorial Hospital
Greensboro, North Carolina, 27401, United States
-
FirstHealth Moore Regional Hospital
Pinehurst, North Carolina, 28374, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Intermountain Medical Center
Murray, Utah, 84107, United States
-
Kansas University Medical Center
Kansas City, Kansas, 66103, United States
-
Mayo Clinic
Rochester, Minnesota, 55902, United States
-
Mercy Hospital of Buffalo
Buffalo, New York, 14220, United States
-
Methodist Hospital
San Antonio, Texas, 78229, United States
-
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
Orlando Health Orlando Regional Medical Center
Orlando, Florida, 32806, United States
-
Tulane University
New Orleans, Louisiana, 70112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill slow brain tumor growth after surgery?
- Breathing tube-free lung surgery tested for patients with fragile lungs
- Can standard cancer treatment wake up the immune system? a study investigates.
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Quitlines may double as lung cancer screening boosters
- A mobile app aims to turn health awareness into action — a trial puts it to the test